Clinical trial
Zinc/PSA Ratio as a Novel Biomarker for Prostate Cancer Detection
NCT02013180 is registered in ClinicalTrials.gov with Bagcilar Training and Research Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Zinc/PSA Ratio as a Novel Biomarker for Prostate Cancer Detection
- Lead sponsor
- Bagcilar Training and Research Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2012
- Completion date
- January 31, 2017
- Enrollment
- 480 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer detection